The role of type I and type II tumor necrosis factor (TNF) receptors in the ability of TNF-α to transduce a proliferative signal in the human megakaryoblastic leukemic cell line Mo7e

Cancer Research

Volumn 58, Issue 10, 1998, Pages 2217-2223

  Liu, Richard Y ^a   Fan, Chun ^a   Mitchell, Steven ^a   Chen, Q ^a   Wu, Jerry ^a   Zuckerman, Kenneth S ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GROWTH FACTOR; MITOGENIC AGENT; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 3; RECOMBINANT INTERLEUKIN 4; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; THROMBOPOIETIN; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MEGAKARYOBLAST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CELL DIVISION; HUMANS; INTERLEUKIN-1; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032523843     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Old, L. J. Tumor necrosis factor (TNF). Science (Washington DC), 230: 630-632, 1985.
2. Vilcek, J., and Lee, T. H. Tumor necrosis factor. J. Biol. Chem., 266: 7313-7316, 1991.
3. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., and Williamson, B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA, 72: 3666-3670, 1975.
4. Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y. C. E., Mathison, J., Ulevitch, R., and Cerami, A. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature (Lond.), 316: 552-554, 1985.
5. Loetscher, H., Pan, Y. E., Lahm, H. W., Gentz, R., Brockhaus, M., Tabuchi, H., and Lesslauer, W. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell, 61: 351-359, 1990.
6. Oliff, A. The role of tumor necrosis factor (cachectin) in cachexia. Cell, 54: 141-142, 1988.
7. Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., and Cerami, A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (Lond.), 330: 662-664, 1987.
8. Yocum, D. E., Espersa, L., Dubry, S., Benjamin, J., Volz, R., and Sculderi, P. Characteristics of tumor necrosis factor production in rheumatoid arthritis. Cell. Immunol., 122: 131-145, 1989.
9. Waage, A., Halstensen, A., Shalaby, R., Brandtzaeg, P., Kierulf, P., and Espevik, T. Local production of tumor necrosis factor α, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J. Exp. Med., 170: 1859-1867, 1989.
10. Sherry, B., and Cerami, A. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J. Cell Biol., 107: 1269-1277, 1988.
11. Fiers, W. Tumor necrosis factor: characterization at the molecular, cellular and in vivo level. FEBS Lett., 285: 199-212, 1991.
12. Vassalli, P. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol., 10: 411-452, 1992.
13. Avanzi, G. C., Lista, P., Giovinazzo, B., Miniere, R., Saglio, G., Benetton, G., Coda, R., Cattoretti, G., and Pegoraro, L. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. Br. J. Haematol., 69: 359-366, 1988.
14. Ogura, M., Morishima, Y., Ohno, R., Kato, Y., Hirabayashi, N., Nagura, H., and Saito, H. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood, 66: 1384-1392, 1985.
15. Greenberg, S. M., Rosenthal, D. S., Greely, T. A., Tantravahi, R., and Handin, R. I. Characterization of a new megakaryocytic cell line: the Dami cell. Blood, 72: 1968-1977, 1988.
16. Martin, P., and Papayannopoulou, T. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science (Washington DC), 216: 1233-1235, 1982.
17. Tortolani, P. J., Johnston, J. A., Bacon, C. M., McVicar, D. M., Shimosaka, A., Linnekin, D., Longo, D. L., and O'Shea, J. Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase, JAK2. Blood, 85: 3444-3451, 1995.
18. Liu, R. Y., Li, X., Li, L., and Li, G. C. Expression of human hsp 70 in rat fibroblasts enhance cell survival and facilitates recovery from translational inhibitor following heat shock. Cancer Res., 52: 3667-3673, 1992.
19. Johnson, C. S., Keckler, D. J., Topper, M. I., Braunschweiger, P. G., and Furmanski, P. In vivo hematopoietic effects of recombinant interleukin-1α in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin. Blood, 73: 678-683, 1989.
20. Chen, Q., Olashaw, N., and Wu, J. Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protein kinase kinase activation pathway. J. Biol. Chem., 270: 28499-28502, 1995.
21. Yu, C. L., Prochownik, E. V., Imperiale, M. J., and Jove, R. Attenuation of serum inducibility of immediate early genes by oncoproteins in tyrosine kinase signaling pathways. Mol. Cell. Biol., 13: 2011-2019, 1993.
22. Guy, G. R., Chua, S. P., Wong, N. S., Ng, S. B., and Tan, Y. H. Interleukin 1 and tumor necrosis factor activate common multiple protein kinases in human fibroblasts. J. Biol. Chem., 266: 14343-14353, 1991.
23. Winston, B. W., Remigio, L. K., and Riches, D. W. Preferential involvement of MEK1 in the tumor necrosis factor-α-induced activation of p42mapk/erk2 in mouse macrophages. J. Biol. Chem., 270: 27391-27394, 1995.
24. Rafiee, P., Lee, J. K., Leung, C. C., and Raffin, T. A. TNF-α induces tyrosine phosphorylation of mitogen-activated protein kinase in adherent human neutrophils. J. Immunol., 154: 4785-4792, 1995.
25. Guy, G. R., Ng, S. B., and Chua, S. P. Lymphokine signal transduction. Prog. Growth Factor Res., 2: 45-70, 1990.
26. Le, J., and Vilcek, J. Biology of disease, tumor necrosis factor and interleukin-1: cytokines with multiple overlapping biological activities. Lab. Invest., 56: 234-248, 1987.
27. Dan, K., Gomi, S., Inokuchi, K., Ogata, K., Yamada, T., Ohki, I., Hasegawa, S., and Nomura, T. Effects of interleukin-1 and tumor necrosis factor on megakaryocytopoiesis: mechanism of reactive thrombocytosis. Acta Haematol., 93: 67-72, 1995.
28. Johnson, C. S., Chang, M. J., and Furmanski, P. In vivo hematopoietic effects of tumor necrosis factor-α in normal and erythroleukemic mice: characterization and therapeutic applications. Blood, 72: 1875-1883, 1988.
29. Slordal, L., Muench, M. O., Warren, D. J., and Moore, M. A. S. Radioprotection by murine and human tumor necrosis factor: dose-dependent effects on hematopoiesis in the mouse. Eur. J. Haematol., 43: 428-434, 1989.
30. Lu, L., Welte, K., Gabrilove, J. L., Hangoc, G., Bruno, E., Hoffman, R., and Broxmeyer, H. E. Effect of recombinant human tumor necrosis factor α, recombinant human γ-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin α, and recombinant erythropoietin in serum-free cultures. Cancer Res., 46: 4357-4361, 1986.
31. Snoeck, H. W., Weeks, S., Moulijn, A., Lardon, F., Lenjou, M., Nys, G., Van Ranst, P. C., Van Bockstaele, D. R., and Berneman, Z. N. Tumor necrosis factor α is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor β but not to Interferon γ. J. Exp. Med., 183: 705-710, 1996.
32. Akiyama, Y., Yamaguchi, K., Sato, T., and Abe, K. Tumor necrosis factor-α stimulates colony formation by a megakaryoblastic leukemia cell line, CMK. Jpn. J. Cancer Res., 83: 989-994, 1992.
33. Beutler, B., and Huffel, E. Unraveling function in the TNF ligand and receptor families. Science (Washington DC), 264: 667-668, 1994.
34. Tartaglia, L. A., Weber, R. F., Figari, I. S., Reynolds, C., Palladino, M. A. J., and Goeddel, D. V. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA, 88: 9292-9296, 1991.
35. Espevik, T., Brockhaus, M., Loetscher, H., Nonstad, U., and Shalaby, R. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J. Exp. Med., 171: 415-426, 1990.
36. Tartaglia, L. A., Pennica, D., and Goeddel, D. V. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem., 268: 18542-18548, 1993.